Page last updated: 2024-11-02

pantoprazole and Auricular Fibrillation

pantoprazole has been researched along with Auricular Fibrillation in 3 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Several studies demonstrated that proton pump inhibitors (PPIs) co-administrated with dabigatran in patients with atrial fibrillation (AF) decreased dabigatran trough and peak plasma levels."7.96The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. ( Bánovčin, P; Bolek, T; Galajda, P; Hyrdel, R; Kubisz, P; Mokáň, M; Nosáková, L; Samoš, M; Schnierer, M; Škorňová, I; Stasko, J, 2020)
" She had been on dabigatran for 13 months due to atrial fibrillation and arterial hypertension."7.81[Exfoliative esophagitis while taking dabigatran]. ( Meesmann, M; Scheppach, W, 2015)
"Several studies demonstrated that proton pump inhibitors (PPIs) co-administrated with dabigatran in patients with atrial fibrillation (AF) decreased dabigatran trough and peak plasma levels."3.96The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. ( Bánovčin, P; Bolek, T; Galajda, P; Hyrdel, R; Kubisz, P; Mokáň, M; Nosáková, L; Samoš, M; Schnierer, M; Škorňová, I; Stasko, J, 2020)
" She had been on dabigatran for 13 months due to atrial fibrillation and arterial hypertension."3.81[Exfoliative esophagitis while taking dabigatran]. ( Meesmann, M; Scheppach, W, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Schnierer, M2
Samoš, M2
Bolek, T2
Škorňová, I2
Nosáková, L1
Bánovčin, P2
Galajda, P2
Stasko, J2
Kubisz, P2
Hyrdel, R1
Mokáň, M2
Lipták, P1
Urban, L1
Scheppach, W1
Meesmann, M1

Other Studies

3 other studies available for pantoprazole and Auricular Fibrillation

ArticleYear
The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study.
    Journal of cardiovascular pharmacology, 2020, Volume: 75, Issue:4

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedul

2020
Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?
    European journal of clinical pharmacology, 2019, Volume: 75, Issue:6

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Interactions; Female;

2019
[Exfoliative esophagitis while taking dabigatran].
    Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antithrombins; Atrial Fibrillation

2015